{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T19:43:48Z","timestamp":1703015028030},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00063-019-0604-5","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T14:29:25Z","timestamp":1566916165000},"page":"620-627","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intensivmedizinische Aspekte der Autoimmunenzephalitis"],"prefix":"10.1007","volume":"114","author":[{"given":"A.","family":"G\u00fcnther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. W.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Br\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"key":"604_CR1","first-page":"476","volume-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","author":"CG Bien","year":"2012","unstructured":"Bien\u00a0CG, R\u00fcegg\u00a0S, Schmutzhard\u00a0E et al (2012) Immunvermittelte Erkrankungen der grauen ZNS-Substanz sowie Neurosarkoidose. In: Diener\u00a0HC, Putzki\u00a0N (Hrsg) Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart\/New York, S 476\u2013448"},{"key":"604_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","volume":"96","author":"J Broadley","year":"2019","unstructured":"Broadley\u00a0J, Seneviratne\u00a0U, Beech\u00a0P et\u00a0al (2019) Prognosticating autoimmune encephalitis: a systematic review. J\u00a0Autoimmun 96:24\u201334","journal-title":"J Autoimmun"},{"key":"604_CR3","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1093\/brain\/awu142","volume":"137","author":"A Carvajal-Gonzalez","year":"2014","unstructured":"Carvajal-Gonzalez\u00a0A, Leite\u00a0MI, Waters\u00a0P et al (2014) Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes. Brain 137:2178\u20132192","journal-title":"Brain"},{"key":"604_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau\u00a0J, Geis\u00a0C, Graus\u00a0F (2017) Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev 97:839\u2013887","journal-title":"Physiol Rev"},{"key":"604_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/CCM.0b013e3181cb0968","volume":"38","author":"G Davies","year":"2010","unstructured":"Davies\u00a0G, Irani\u00a0SR, Coltart\u00a0C et al (2010) Anti-N-methyl-D-aspartate receptor antibodies: a\u00a0potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med 38:679\u2013682","journal-title":"Crit Care Med"},{"key":"604_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1164\/rccm.201603-0507OC","volume":"195","author":"E De Montmollin","year":"2017","unstructured":"De Montmollin\u00a0E, Demeret\u00a0S, Brule\u00a0N et al (2017) Anti-N-methyl-D-aspartate receptor encephalitis in adult patients requiring intensive care. Am J Respir Crit Care Med 195:491\u2013499","journal-title":"Am J Respir Crit Care Med"},{"key":"604_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s00115-012-3710-7","volume":"84","author":"S Ehrlich","year":"2013","unstructured":"Ehrlich\u00a0S, Fassbender\u00a0C, Blaes\u00a0F et\u00a0al (2013) Therapeutische Apherese bei Patienten mit autoimmuner Enzephalitis, eine bundesweite Datenerhebung. Nervenarzt 84:498\u2013507","journal-title":"Nervenarzt"},{"key":"604_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","volume":"83","author":"C Finke","year":"2012","unstructured":"Finke\u00a0C, Kopp\u00a0U, Pr\u00fcss\u00a0H et al (2012) Cognitive deficits following anti-NMDA receptor encephalitis. J\u00a0Neurol Neurosurg Psychiatry 83:195\u2013198","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"604_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan\u00a0EP, Hinson\u00a0SR, Lennon\u00a0VA et\u00a0al (2017) Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients. Ann Neurol 81:298\u2013309","journal-title":"Ann Neurol"},{"key":"604_CR10","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","volume":"10","author":"J Granerod","year":"2010","unstructured":"Granerod\u00a0J, Ambrose\u00a0HE, Davies\u00a0NW et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a\u00a0multicentre, population-based prospective study; UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group. Lancet Infect Dis 10:835\u2013844","journal-title":"Lancet Infect Dis"},{"key":"604_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus\u00a0F, Titulaer\u00a0MJ, Balu\u00a0R et\u00a0al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391\u2013404","journal-title":"Lancet Neurol"},{"key":"604_CR12","first-page":"1997","volume":"80","author":"C Gumbinger","year":"2013","unstructured":"Gumbinger\u00a0C, Hametner\u00a0C, Wildemann\u00a0B et al (2013) Administration of Isoflurane controlled dyskinetic movements caused by Anti-NMDAR encephalitis. Baillieres Clin Neurol 80:1997\u20131998","journal-title":"Baillieres Clin Neurol"},{"key":"604_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-0042-121845","volume":"13","author":"A G\u00fcnther","year":"2017","unstructured":"G\u00fcnther\u00a0A, Schubert\u00a0J, Witte\u00a0OW, Br\u00e4mer\u00a0D (2017) Intensivmedizinische Komplikationen autoimmuner Enzephalitiden. Intensivmedup2date 13:91\u2013106","journal-title":"Intensivmed.up2date"},{"key":"604_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s13054-015-0993-7","volume":"19","author":"G Hermans","year":"2015","unstructured":"Hermans\u00a0G, Van den Berghe\u00a0G (2015) Clinical review: intensive care acquired weakness. Crit Care 19:274","journal-title":"Crit Care"},{"key":"604_CR15","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1001\/jama.2010.1553","volume":"304","author":"TJ Iwashyna","year":"2010","unstructured":"Iwashyna\u00a0TJ, Ely\u00a0EW, Smith\u00a0DM et al (2010) Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304:1787\u20131794","journal-title":"JAMA"},{"key":"604_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s42451-018-0051-1","author":"W K\u00f6hler","year":"2019","unstructured":"K\u00f6hler\u00a0W, Bien\u00a0CG, Ehrlich\u00a0E et\u00a0al (2019) Konsensuspapier zum Einsatz der therapeutischen Apherese in der Neurologie. DGNeurologie. \n                    https:\/\/doi.org\/10.1007\/s42451-018-0051-1","journal-title":"DGNeurologie"},{"key":"604_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12028-015-0196-8","volume":"24","author":"MK Mittal","year":"2016","unstructured":"Mittal\u00a0MK, Rabinstein\u00a0AA, Hocker\u00a0SE et\u00a0al (2016) Autoimmune encephalitis in the ICU: analysis of phenotypes, serologic findings, and outcomes. Neurocrit Care 24:240\u2013250","journal-title":"Neurocrit Care"},{"key":"604_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clineuro.2014.10.015","volume":"128","author":"M Satain","year":"2015","unstructured":"Satain\u00a0M, Roguski\u00a0M, Kryzanski\u00a0T et\u00a0al (2015) A review of the combined medical and surgical management in patients with herpes simplex encephalitis. Clin Neurol Neurosurg 128:10\u201316","journal-title":"Clin. Neurol. Neurosurg."},{"key":"604_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1212\/WNL.0000000000003536","volume":"88","author":"F Scheibe","year":"2017","unstructured":"Scheibe\u00a0F, Pr\u00fcss\u00a0H, Mengel\u00a0AM et al (2017) Bortezomib for treatment of therapy-refractory anti-NMDA reeptor encephalitis. Neurology 88:366\u2013370","journal-title":"Neurology"},{"key":"604_CR20","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1212\/WNL.0b013e3182698cd8","volume":"79","author":"SE Schmitt","year":"2012","unstructured":"Schmitt\u00a0SE, Pargeon\u00a0K, Frechette\u00a0ES et al (2012) Extreme delta brush: a\u00a0unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 79:1094\u20131100","journal-title":"Neurology"},{"key":"604_CR21","doi-asserted-by":"publisher","first-page":"e514","DOI":"10.1212\/NXI.0000000000000514","volume":"6","author":"J Schubert","year":"2019","unstructured":"Schubert\u00a0J, Br\u00e4mer\u00a0D, Huttner\u00a0HB et\u00a0al (2019) Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment. Neurol Neuroimmunol Neuroinflamm 6:e514\u201310","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"604_CR22","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1007\/s00134-016-4504-3","volume":"42","author":"trials Group","year":"2016","unstructured":"trials Group (2016) Incidence of severe sepsis and septic shock in German intensive care units: the prospective, multicentre INSEP study. Intensive Care Med 42:1980\u20131989","journal-title":"Intensive Care Med"},{"key":"604_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1212\/WNL.0000000000001190","volume":"84","author":"TD Singh","year":"2015","unstructured":"Singh\u00a0TD, Fugate\u00a0JE, Rabinstein\u00a0AA (2015) The spectrum of acute encephalitis: causes, management, and predictors of outcome. Neurology 84:359\u2013366","journal-title":"Neurology"},{"key":"604_CR24","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"M Titulaer","year":"2013","unstructured":"Titulaer\u00a0M, McCracken\u00a0L, Gabilondo\u00a0I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157\u2013165","journal-title":"Lancet Neurol"},{"key":"604_CR25","first-page":"666","volume":"115","author":"KP Wandinger","year":"2018","unstructured":"Wandinger\u00a0KP, Leypoldt\u00a0F, Junker\u00a0R (2018) Autoantibody-mediated encephalitis-differential diagnosis in patients with impaired consciousness of unclear origin. Dtsch Arztebl Int 115:666\u2013673","journal-title":"Dtsch Arztebl Int"},{"key":"604_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.brs.2018.11.016","volume":"12","author":"N Warren","year":"2019","unstructured":"Warren\u00a0N, Grote\u00a0V, Gorman\u00a0C et al (2019) Electroconvulsive therapy for anti-N-methyl-D-aspartate receptor encephalitis: a\u00a0systematic review of cases. Brain Stimul 12:329\u2013334","journal-title":"Brain Stimul"},{"key":"604_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.14503\/THIJ-13-3987","volume":"42","author":"B Ziaeian","year":"2015","unstructured":"Ziaeian\u00a0B, Shamsa\u00a0K (2015) Dazed, confused, and Asystolic: possible signs of anti\u2013N-methyl-d-Aspartate receptor encephalitis. Tex Heart Inst\u00a0J 42:175\u2013177","journal-title":"Tex Heart Inst J"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-019-0604-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-019-0604-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-019-0604-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T23:15:15Z","timestamp":1598397315000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-019-0604-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1007\/s00063-019-0604-5","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"8 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0G\u00fcnther erhielt Reisekostenerstattung und\/oder Vortragshonorare von den Firmen Merz, Ipsen, Boehringer Ingelheim, Pfizer, Daiichi Sankyo, and Bayer. O.W.\u00a0Witte arbeitete in den Editorial Boards von \u201eDas Neurophysiologie-Labor\u201c und die \u201eZeitschrift f\u00fcr klinische Neurophysiologie\u201c mit. Er erhielt Forschungsgelder von der DFG, dem Th\u00fcringer Ministerium f\u00fcr Bildung, Wissenschaft und Kultur, dem Bundesministerium f\u00fcr Forschung und Technik und der Europ\u00e4ischen Union. J.\u00a0Schubert und D.\u00a0Br\u00e4mer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}